Results 41 to 50 of about 1,467,276 (295)

Radar HRRP Modeling using Dynamic System for Radar Target Recognition [PDF]

open access: yes, 2014
High resolution range profile (HRRP) is being known as one of the most powerful tools for radar target recognition. The main problem with range profile for radar target recognition is its sensitivity to aspect angle. To overcome this problem, consecutive
Ajorloo, A.   +3 more
core  

Bismuth incorporation and the role of ordering in GaAsBi/GaAs structures [PDF]

open access: yes, 2014
The structure and composition of single GaAsBi/GaAs epilayers grown by molecular beam epitaxy were investigated by optical and transmission electron microscopy techniques.
Bastiman, Faebian   +6 more
core   +2 more sources

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

Adaptive soft threshold transformer for radar high‐resolution range profile target recognition

open access: yesIET Radar, Sonar & Navigation
Radar High‐Resolution Range Profile (HRRP) has great potential for target recognition because it can provide target structural information. Existing work commonly applies deep learning to extract deep features from HRRPs and achieve impressive ...
Siyu Chen, Xiaohong Huang, Weibo Xu
doaj   +1 more source

Scattering Mechanism Identification Based on Polarimetric HRRP of Manmade Target

open access: yesLeida xuebao, 2016
In this paper, we analyze the space polarization and frequency dispersion characteristics of the polarimetric High Resolution Range Profile (HRRP) of manmade targets.
Wu Jiani   +4 more
doaj   +1 more source

Testing adiabatic contraction of dark matter in fossil group candidates

open access: yes, 2010
We present deep XMM observations and ESO WFI optical imaging of two X-ray-selected fossil group candidates, RXCJ0216.7-4749 and RXCJ2315.7-0222. Using the X-ray data, we derive total mass profiles under the hydrostatic equilibrium assumption. The central
Allen   +72 more
core   +1 more source

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson   +3 more
wiley   +1 more source

Wideband Spectroscopy of Two Radio Bursts on AD Leonis

open access: yes, 2005
We report high-time-resolution, broadband spectroscopic observations of two radio bursts on the classical flare star AD Leonis. The observations were acquired by the 305 m telescope at Arecibo Observatory on 2003 June 13-14.
Bastian, T. S., Osten, R. A.
core   +1 more source

Feasibility and Safety of High‐Dose Proton Re‐Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single‐Institution Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Pediatric central nervous system (CNS) tumors often recur despite multimodality therapy. Although re‐irradiation (re‐RT) has historically been limited by concerns for severe late toxicities, modern techniques have renewed interest in this approach. Proton therapy provides dosimetric advantages that may enable curative re‐treatment with
Jin‐Ho Song   +15 more
wiley   +1 more source

Blinatumomab Utilization in Pediatric B‐Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Blinatumomab is a bispecific T‐cell engager approved for the treatment of pediatric B‐cell acute lymphoblastic leukemia (B‐ALL). Outpatient home infusion reduces hospitalization burden and optimizes resource utilization, but is logistically challenging.
Angela Parra del Riego   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy